Hyperion DeFi (HYPD) vs Serina Therapeutics (SER)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Hyperion DeFi (HYPD) has outperformed Serina Therapeutics (SER) over the past year, losing 61.6% versus a loss of 62.8%. Over five years, SER leads with a -93.9% price change compared with -99.2% for HYPD. Hyperion DeFi is the larger company by market cap ($51.5 million vs $51.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HYPD | SER |
|---|---|---|
| Share price | $3.39 | $2.02 |
| Market cap | $51.53M | $51.31M |
| 1-day change | -5.61% | +0.23% |
| YTD return | +0.84% | +5.07% |
| 1-year return | -61.60% | -62.78% |
| 5-year return | -99.15% | -93.88% |
| EPS (TTM) | $-6.46 | $-1.87 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $9.50 | $5.71 |
| 52-week low | $2.34 | $1.22 |
| Distance from 52-week high | -64.32% | -64.63% |
| Average volume | 445.34K | 64.02K |
| Shares outstanding | 15.20M | 25.40M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
HYPD vs SER FAQ
Which is bigger, Hyperion DeFi or Serina Therapeutics?
Hyperion DeFi (HYPD) is larger, with a market capitalization of $51.53M compared with $51.31M for Serina Therapeutics (SER).
Which stock has performed better over the past year, HYPD or SER?
HYPD returned -61.60% over the past 12 months, compared with -62.78% for SER (price return, excluding dividends). Past performance does not predict future results.
Are Hyperion DeFi and Serina Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.